Low body temperature does not compromise the treatment effect of alteplase.
about
Initial body temperature in ischemic stroke: nonpotentiation of tissue-type plasminogen activator benefit and inverse association with severityTargeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia.Body temperature and major neurological improvement in tPA-treated stroke patients.Body temperature, blood infection parameters, and outcome of thrombolysis-treated ischemic stroke patients.Increased benefit of alteplase in patients with ischemic stroke and a high body temperature.Elevated body temperature in ischemic stroke associated with neurological improvement.
P2860
Low body temperature does not compromise the treatment effect of alteplase.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Low body temperature does not compromise the treatment effect of alteplase.
@ast
Low body temperature does not compromise the treatment effect of alteplase.
@en
type
label
Low body temperature does not compromise the treatment effect of alteplase.
@ast
Low body temperature does not compromise the treatment effect of alteplase.
@en
prefLabel
Low body temperature does not compromise the treatment effect of alteplase.
@ast
Low body temperature does not compromise the treatment effect of alteplase.
@en
P2093
P1433
P1476
Low body temperature does not compromise the treatment effect of alteplase
@en
P2093
Ashfaq Shuaib
Monica Saini
Patrick D Lyden
Virtual International Stroke Trials Archive (VISTA) Collaborators
P304
P356
10.1161/STROKEAHA.110.611210
P407
P577
2011-07-14T00:00:00Z